Pro-Dex Revenue Jumps 16% in Fiscal Q4

Pro-Dex (NASDAQ:PDEX), a developer and manufacturer of powered surgical instruments for medical device OEMs, released its Q4 FY2025 earnings on Sept. 4, 2025. The company reported GAAP revenue of $17.5 million, up from $15.0 million a year earlier, but faces margin pressure as gross margin contracted to 20%. Net income (GAAP) fell to $1.2 million, with diluted earnings per share at $0.36. These results showed top-line growth in line with recent management emphasis, but also highlighted new cost and margin risks facing the business. Overall, the quarter demonstrated growth momentum, with caution signals on profitability and working capital.Source: Pro-Dex. Note: Fiscal 2025's fourth quarter ended June 30, 2025. Fiscal 2024's Q4 ended June 30, 2024.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool